CVRx, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CVRX Nasdaq 3840 www.cvrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CVRx, Inc.

CVRx (CVRX) Expected to Beat Earnings Estimates: Should You Buy? - Jan 16th, 2025 3:00 pm
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance - Jan 13th, 2025 1:00 pm
Institutions own 39% of CVRx, Inc. (NASDAQ:CVRX) shares but private equity firms control 39% of the company - Dec 30th, 2024 12:50 pm
CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Dec 23rd, 2024 9:30 pm
Cvrx (CVRX) Declined Due To Turbulence In The Direct Sales Team - Nov 26th, 2024 1:31 pm
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference - Nov 20th, 2024 9:30 pm
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025 - Nov 4th, 2024 1:00 pm
CVRx, Inc. (NASDAQ:CVRX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Nov 1st, 2024 11:57 am
CVRx Inc (CVRX) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Rising Expenses - Oct 30th, 2024 7:14 am
CVRx (CVRX) Reports Q3 Loss, Tops Revenue Estimates - Oct 29th, 2024 9:50 pm
CVRx: Q3 Earnings Snapshot - Oct 29th, 2024 8:46 pm
CVRx Reports Third Quarter 2024 Financial and Operating Results - Oct 29th, 2024 8:05 pm
CVRx (CVRX) Soars 17.2%: Is Further Upside Left in the Stock? - Oct 21st, 2024 12:42 pm
CVRx announces new CPT Category I codes for Barostim heart failure therapy - Oct 21st, 2024 10:40 am
CVRx announces new CPT Category I codes for Barostim - Oct 19th, 2024 6:10 pm
CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024 - Oct 15th, 2024 8:30 pm
CVRX Stock Gains on Unveiling of Barostim's Positive Study Data - Sep 16th, 2024 2:37 pm
CVRx touts positive two-year data for heart failure neuromodulation device - Sep 12th, 2024 2:13 pm
CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim - Sep 12th, 2024 12:00 pm
CVRx Announces Appointment of Two New Board Members - Sep 3rd, 2024 12:30 pm